Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study
Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
01EO1302
German Federal Ministry of Education and Research - International
Dietmar Hopp Stiftung - International
Astellas and Novartis - International
LO1503
National Sustainability Program I (NPU I) - International
Czech Ministry of Education, Youth and Sports - International
FP7-HEALTH-2012-INNOVATION-1-305499
European consortium Biomargin - International
PubMed
30357927
DOI
10.1111/tri.13363
Knihovny.cz E-zdroje
- Klíčová slova
- biomarker, chronic active antibody-mediated rejection, proteomics,
- MeSH
- biologické markery moč MeSH
- biopsie MeSH
- dítě MeSH
- imunosupresiva terapeutické užití MeSH
- lidé MeSH
- mladiství MeSH
- pilotní projekty MeSH
- plocha pod křivkou MeSH
- předškolní dítě MeSH
- přežívání štěpu MeSH
- proteomika * MeSH
- protilátky imunologie MeSH
- rejekce štěpu imunologie MeSH
- renální insuficience moč MeSH
- ROC křivka MeSH
- senzitivita a specificita MeSH
- studie případů a kontrol MeSH
- transplantace ledvin * MeSH
- žijící dárci MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- biologické markery MeSH
- imunosupresiva MeSH
- protilátky MeSH
Chronic antibody-mediated rejection (cABMR) is the main cause of long-term renal graft loss. Late-stage diagnosis is made by detecting donor-specific antibodies (DSA) in blood combined with typical histomorphological lesions in renal allografts. There is a need for noninvasive biomarkers for cABMR that might permit screening and earlier diagnosis. In a case control study of 24 pediatric renal transplant recipients, urine samples were analyzed using capillary electrophoresis and mass spectrometry. Patients were matched with 36 pediatric renal transplant patients without cABMR. Statistical analysis used the nonparametric Wilcoxon test to identify 79 significant biomarkers, which were combined to a support vector machine-based classifier. After validation in an independent test cohort of eight pediatric patients with and 12 without cABMR, the area under the receiver operating characteristic (ROC) curve (AUC) for detection of cABMR was 0.92 (95% CI 0.71-0.99) with a sensitivity of 100% (95% CI 63-100%) and a specificity of 75% (95% CI 43-95%). Combining this classifier with the urinary proteomic marker CKD273 improved the detection of patients with cABMR with misclassification in only 2/20 of the patients. These data indicate that a biomarker pattern derived from urinary proteomics allows the detection of cABMR in pediatric renal transplant recipients with high sensitivity and moderate specificity.
Clementine Kinderhospital Frankfurt Germany
Department of Pediatric 1 University Children's Hospital Heidelberg Germany
Department of Pediatric Nephrology Hannover Medical School Hannover Germany
Department of Pediatric Nephrology University Hospital of Vienna Vienna Austria
Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK
Integrated Research and Treatment Center Transplantation Hannover Germany
Citace poskytuje Crossref.org